German Biopharmaceutical Company CureVac's MRNA-based #vaccine Has Shown Efficacy of Just ... - Latest Tweet by IANS Tweets
The latest Tweet by IANS Tweets states, 'German biopharmaceutical company CureVac's mRNA-based #vaccine has shown efficacy of just 47 per cent against #Coronavirus disease, the lowest reported so far from any #Covid19 vaccine maker, according to the preliminary results of a clinical trial reported on Wednesday.'
German biopharmaceutical company CureVac's mRNA-based #vaccine has shown efficacy of just 47 per cent against #Coronavirus disease, the lowest reported so far from any #Covid19 vaccine maker, according to the preliminary results of a clinical trial reported on Wednesday. pic.twitter.com/czWhlJMADN— IANS Tweets (@ians_india) June 17, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Jun 17, 2021 03:12 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
